Scholarlink

<p>Intervertebral disc degeneration (IVDD) is fundamentally driven by a self-perpetuating pathological loop involving metabolic derangement, oxidative stress, and enzymatic hyper-activity. Conventional mono-therapies often fall short of reversing this complex microenvironmental collapse. Here, we developed a smart nano-glycosphere (siMMP13/2-DG NPs) designed for dual-track intervention to restore disc homeostasis. This responsive platform utilized a 2-deoxy-D-glucose (2-DG) shell crosslinked via reactive oxygen-sensitive phenylboronic acid moieties, enabling the simultaneous suppression of pathological glycolysis and the neutralization of oxidative stress. Concomitantly, the precise delivery of siMMP13 effectively silenced major catabolic enzymes, thereby arresting extracellular matrix degradation. Our findings demonstrated that this combinatorial approach effectively interrupted the lactate-driven inflammatory cascade, shifting the microenvironment from a hostile catabolic state toward a pro-regenerative metabolic balance. In the lumbar disc degeneration model, the siMMP13/2-DG NPs significantly preserved structural integrity and alleviated discogenic pain by dampening neuro-inflammatory signaling. By integrating metabolic reprogramming with targeted gene silencing, this study establishes a versatile therapeutic paradigm for the precision management of IVDD and offers broader insights into the treatment of other microenvironment-mediated musculoskeletal disorders.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pathological microenvironment-responsive nano-glycospheres restore disc homeostasis by combinatorial metabolic and genetic regulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月22日

查看全文
  • Lei Zhao,
  • Wenzheng Ma,
  • Wantao Wang,
  • Dan Zhou,
  • Jinghao Fan,
  • Mingkang Liu,
  • Lei Liu,
  • Lin Huang,
  • Xue Wei,
  • Zhaomin Zheng,
  • Hongmei Liu,
  • Decheng Wu

摘要

Intervertebral disc degeneration (IVDD) is fundamentally driven by a self-perpetuating pathological loop involving metabolic derangement, oxidative stress, and enzymatic hyper-activity. Conventional mono-therapies often fall short of reversing this complex microenvironmental collapse. Here, we developed a smart nano-glycosphere (siMMP13/2-DG NPs) designed for dual-track intervention to restore disc homeostasis. This responsive platform utilized a 2-deoxy-D-glucose (2-DG) shell crosslinked via reactive oxygen-sensitive phenylboronic acid moieties, enabling the simultaneous suppression of pathological glycolysis and the neutralization of oxidative stress. Concomitantly, the precise delivery of siMMP13 effectively silenced major catabolic enzymes, thereby arresting extracellular matrix degradation. Our findings demonstrated that this combinatorial approach effectively interrupted the lactate-driven inflammatory cascade, shifting the microenvironment from a hostile catabolic state toward a pro-regenerative metabolic balance. In the lumbar disc degeneration model, the siMMP13/2-DG NPs significantly preserved structural integrity and alleviated discogenic pain by dampening neuro-inflammatory signaling. By integrating metabolic reprogramming with targeted gene silencing, this study establishes a versatile therapeutic paradigm for the precision management of IVDD and offers broader insights into the treatment of other microenvironment-mediated musculoskeletal disorders.

Graphical Abstract